Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121748078 | 12174807 | 8 | F | 2016 | 20160726 | 20160314 | 20160803 | EXP | CA-ALEXION PHARMACEUTICALS INC-A201601681 | ALEXION | 80.26 | YR | M | Y | 91.00000 | KG | 20160803 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121748078 | 12174807 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, QW | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
| 121748078 | 12174807 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | AD9022B01 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121748078 | 12174807 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | AE7317B04 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121748078 | 12174807 | 4 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | Oral | UNK, QHS | 0 | QD | |||||||||
| 121748078 | 12174807 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 121748078 | 12174807 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | UNK MG, UNK | 0 | ||||||||||
| 121748078 | 12174807 | 7 | C | COLCHICINE. | COLCHICINE | 1 | Oral | 1.2 MG, QD | 0 | 1.2 | MG | QD | |||||||
| 121748078 | 12174807 | 8 | C | FELODIPINE. | FELODIPINE | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
| 121748078 | 12174807 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK, QD | 0 | QD | |||||||||
| 121748078 | 12174807 | 10 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | Unknown | UNK, QD | 0 | QD | |||||||||
| 121748078 | 12174807 | 11 | C | B100 | MINERALSVITAMINS | 1 | Unknown | UNK, QD | 0 | QD | |||||||||
| 121748078 | 12174807 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK, QMONTH | 0 | INJECTION | /month | ||||||||
| 121748078 | 12174807 | 13 | C | PERINDOPRIL ERBUMINE. | PERINDOPRIL ERBUMINE | 1 | Unknown | 2 MG, QD | 0 | 2 | MG | QD | |||||||
| 121748078 | 12174807 | 14 | C | COVERSYL /00790702/ | PERINDOPRIL | 1 | Unknown | 0 | |||||||||||
| 121748078 | 12174807 | 15 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 4 MG, QD | 0 | 4 | MG | QD | |||||||
| 121748078 | 12174807 | 16 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 121748078 | 12174807 | 17 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, BID | 0 | 25 | MG | BID | |||||||
| 121748078 | 12174807 | 18 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 2MG / 1MG ALTERNATE DAYS | 0 | ||||||||||
| 121748078 | 12174807 | 19 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 325 MG, PRN 2 TAB | 0 | 325 | MG | TABLET | /yr | ||||||
| 121748078 | 12174807 | 20 | C | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 100 ?G, UNK | 0 | 100 | UG | ||||||||
| 121748078 | 12174807 | 21 | C | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 300 ?G, QW | 0 | 300 | UG | /wk | |||||||
| 121748078 | 12174807 | 22 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | 2000 IU, QD | 0 | 2000 | IU | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121748078 | 12174807 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 121748078 | 12174807 | 4 | Pain in extremity |
| 121748078 | 12174807 | 5 | Gout |
| 121748078 | 12174807 | 7 | Gout |
| 121748078 | 12174807 | 8 | Product used for unknown indication |
| 121748078 | 12174807 | 9 | Product used for unknown indication |
| 121748078 | 12174807 | 10 | Product used for unknown indication |
| 121748078 | 12174807 | 11 | Product used for unknown indication |
| 121748078 | 12174807 | 12 | Product used for unknown indication |
| 121748078 | 12174807 | 13 | Product used for unknown indication |
| 121748078 | 12174807 | 14 | Hypertension |
| 121748078 | 12174807 | 15 | Hypertension |
| 121748078 | 12174807 | 16 | Product used for unknown indication |
| 121748078 | 12174807 | 18 | Product used for unknown indication |
| 121748078 | 12174807 | 19 | Pain |
| 121748078 | 12174807 | 20 | Product used for unknown indication |
| 121748078 | 12174807 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121748078 | 12174807 | HO |
| 121748078 | 12174807 | OT |
| 121748078 | 12174807 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121748078 | 12174807 | Hypotension | |
| 121748078 | 12174807 | Inappropriate schedule of drug administration | |
| 121748078 | 12174807 | Infection | |
| 121748078 | 12174807 | Mobility decreased | |
| 121748078 | 12174807 | Oxygen saturation decreased | |
| 121748078 | 12174807 | Pain | |
| 121748078 | 12174807 | Renal failure | |
| 121748078 | 12174807 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121748078 | 12174807 | 1 | 20100309 | 20100331 | 0 | |
| 121748078 | 12174807 | 2 | 20100407 | 0 | ||
| 121748078 | 12174807 | 3 | 20100407 | 20160713 | 0 | |
| 121748078 | 12174807 | 5 | 2008 | 0 | ||
| 121748078 | 12174807 | 6 | 201306 | 0 | ||
| 121748078 | 12174807 | 7 | 201202 | 0 | ||
| 121748078 | 12174807 | 13 | 201105 | 0 | ||
| 121748078 | 12174807 | 15 | 201107 | 0 | ||
| 121748078 | 12174807 | 17 | 201411 | 0 | ||
| 121748078 | 12174807 | 20 | 20140723 | 0 | ||
| 121748078 | 12174807 | 21 | 20140910 | 0 |